Evidence map›Paper›PMID 40563860›Full record

ArticleBiology2025

Evaluation of Type 2 Diabetes Risk in Individuals With or Without Metabolically Healthy Obesity.

Miguel García Samuelsson, Pedro Juan Tárraga López, Ángel Arturo López-González, Carla Busquets-Cortés, Joan Obrador de Hevia, José Ignacio Ramírez-Manent

Abstract read
In one paragraph

Article in Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Miguel García SamuelssonADEMA-Health Group, University Institute of Health Sciences (IUNICS), 07120 Palma de Mallorca, Spain.
Pedro Juan Tárraga LópezFaculty of Medicine, University of Castilla-La Mancha, 02071 Albacete, Spain.ORCID 0000-0002-5222-5784
Ángel Arturo López-GonzálezADEMA-Health Group, University Institute of Health Sciences (IUNICS), 07120 Palma de Mallorca, Spain.ORCID 0000-0002-7439-8117
Carla Busquets-CortésADEMA-Health Group, University Institute of Health Sciences (IUNICS), 07120 Palma de Mallorca, Spain.ORCID 0000-0001-9367-2137
Joan Obrador de HeviaADEMA-Health Group, University Institute of Health Sciences (IUNICS), 07120 Palma de Mallorca, Spain.ORCID 0000-0002-8482-1054
José Ignacio Ramírez-ManentADEMA-Health Group, University Institute of Health Sciences (IUNICS), 07120 Palma de Mallorca, Spain.ORCID 0000-0001-6887-4562

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe concept of metabolically healthy obesity (MHO) has emerged as a controversial yet clinically relevant phenotype, challenging the traditional view that all obese individuals are uniformly at high metabolic risk. However, the long-term health implications of MHO, particularly its association with type 2 diabetes mellitus (T2DM), remain poorly defined.

objectiveTo assess the risk of T2DM in individuals with MHO compared to those with metabolically non-healthy obesity (MNHO), using multiple validated diabetes risk scales across a large population-based cohort.

methodsThis cross-sectional study analyzed data from over 68,884 adults stratified by sex and BMI-defined obesity status. Metabolic health was categorized using three progressively inclusive definitions based on the number of metabolic syndrome components. Diabetes risk was estimated using Finrisk, Canrisk, TRAQ-D, Thai, Oman, and QD-score tools. Multinomial logistic regression assessed associations between MHO/MNHO phenotypes and high-risk diabetes scores, adjusting for demographic, socioeconomic, and lifestyle variables.

resultsAcross all definitions and scales, MNHO individuals exhibited significantly higher mean diabetes risk scores and greater prevalence of high-risk categories compared to MHO participants (

conclusionsWhile MHO individuals present a comparatively lower risk of T2DM than their MNHO counterparts, their risk remains substantially higher than that of non-obese individuals. These findings highlight the need to refine risk stratification approaches beyond BMI alone, and to consider metabolic health status in guiding prevention strategies for T2DM.

Indexed as

diabetes risk scalesmetabolically healthy obesitymetabolic syndromeobesity phenotypespopulation-based studytype 2 diabetes risk

Identifiers

PMID40563860
PMCPMC12189814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.